HYFT.US MindWalk Holdings Corp.
- Market cap
- USD 47.1M
- P/E
- -
- P/B
- 10.11x
- ROE
- -357.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is HYFT.US undervalued?
Graham numberThe Graham number of MindWalk Holdings Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MindWalk Holdings Corp. fundamental analysis
No fundamental analysis for MindWalk Holdings Corp. yet.
MindWalk Holdings Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MindWalk Holdings Corp.
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company is headquartered in Austin, Texas.
Full company profileMindWalk Holdings Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MindWalk Holdings Corp. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.63M | 5.44M | 10.9M | 14.7M | 17.9M | 19.4M | 20.7M | 24.5M | 24.5M | 15.3M | 15.6M |
| Gross Profit | 1.42M | 2.45M | 5.29M | -576K | 11.5M | 11.0M | 11.6M | 12.1M | 13.5M | 9.01M | 9.12M |
| Operating Income | -1.39M | -4.93M | -6.23M | -4.29M | -4.18M | -16.7M | -25.6M | -13.8M | -12.2M | -14.7M | -24.9M |
| EBITDA | -5.40M | -4.35M | -4.03M | -1.40M | -1.42M | -12.0M | -21.0M | -22.9M | -28.9M | -13.1M | -23.8M |
| Net Income | -5.38M | -5.17M | -7.62M | -5.18M | -7.34M | -16.7M | -26.6M | -26.1M | -30.2M | -13.7M | -24.7M |
| EPS | -1.36 | -0.57 | -0.61 | -0.38 | -0.45 | -0.85 | -1.07 | -1.02 | -0.91 | -0.30 | -0.53 |
| Balance Sheet | |||||||||||
| Total Assets | 3.93M | 24.6M | 28.3M | 27.3M | 67.0M | 93.5M | 77.8M | 60.0M | 44.4M | 21.3M | 17.3M |
| Total Liabilities | 837K | 11.9M | 10.3M | 12.2M | 10.0M | 18.4M | 20.0M | 26.1M | 20.8M | 9.61M | 10.4M |
| Shareholders' Equity | 3.09M | 12.7M | 18.1M | 15.1M | 56.9M | 75.3M | 57.8M | 33.9M | 23.6M | 11.7M | 6.91M |
| Cash & Short-term Investments | 2.58M | 1.81M | 5.47M | 2.61M | 41.8M | 30.0M | 8.28M | 3.46M | 10.7M | 11.3M | 7.63M |
| Total Debt | - | 3.82M | 2.93M | 4.51M | 4.26M | 2.77M | 14.3M | 13.7M | 13.4M | 3.52M | 3.49M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -722K | -3.42M | -3.21M | -1.39M | -600K | -9.92M | -19.8M | -4.25M | -6.41M | -12.3M | -16.4M |
| Capital Expenditure | 531K | 345K | 645K | 576K | 1.43M | 1.26M | 1.50M | 1.40M | 799K | 392K | 317K |
| Free Cash Flow | -1.25M | -3.76M | -3.85M | -1.97M | -2.03M | -11.2M | -21.3M | -5.64M | -7.21M | -12.7M | -16.7M |
| Ratios | |||||||||||
| ROE | -174.1% | -40.7% | -42.2% | -34.3% | -12.9% | -22.2% | -45.9% | -77.0% | -128.0% | -117.1% | -357.6% |
| ROA | -137.0% | -21.0% | -26.9% | -19.0% | -11.0% | -17.9% | -34.1% | -43.5% | -68.0% | -64.4% | -142.6% |
| Net Profit Margin | -204.7% | -95.0% | -69.7% | -35.2% | -41.0% | -86.3% | -128.5% | -106.5% | -123.3% | -89.7% | -158.7% |
| Debt to Equity | - | 0.30x | 0.16x | 0.30x | 0.07x | 0.04x | 0.25x | 0.40x | 0.57x | 0.30x | 0.50x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MindWalk Holdings Corp. dividends
MindWalk Holdings Corp. has not paid dividends in the last 9 fiscal years.
Last stock split: 1:5 on Nov 23, 2020.
Who owns MindWalk Holdings Corp.
- Insiders 9.25%
- Institutions 9.08%
- Public & others 81.67%
- Shares outstanding 47.6M
- Free float 42.7M
Top funds holding HYFT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Micro-Cap ETF | 131K | 0.28% | 0.00% | Oct 2026 |
| 1290 VT Micro Cap K | 9.59K | 0.02% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 9.36K | 0.02% | -63.30% | Aug 2026 |
Top institutions holding HYFT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Ingalls & Snyder LLC | 3.04M | 6.38% | +4.42% | Jun 2026 |
| Susquehanna International Group, LLP | 521K | 1.09% | -2.48% | Jun 2026 |
| Renaissance Technologies Corp | 177K | 0.37% | -16.92% | Sep 2026 |
| BlackRock Inc | 154K | 0.32% | 0.00% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 136K | 0.29% | +438.57% | Jun 2026 |
| Bank of Montreal | 77.9K | 0.16% | +11.44% | Jun 2026 |
| BMO Capital Markets Corp. | 77.9K | 0.16% | +11.44% | Jun 2026 |
| Allianz Asset Management AG | 35.0K | 0.07% | 0.00% | Jun 2026 |
| GSA Capital Partners LLP | 34.5K | 0.07% | 0.00% | Jun 2026 |
| Gradient Capital Advisors, LLC | 26.6K | 0.06% | 0.00% | Sep 2026 |
| Geode Capital Management, LLC | 25.5K | 0.05% | +57.99% | Jun 2026 |
| Federation des caisses Desjardins du Quebec | 23.3K | 0.05% | 0.00% | Jun 2026 |
| Tradition Wealth Management LLC | 13.2K | 0.03% | 0.00% | Jun 2026 |
| XTX Topco Ltd | 12.3K | 0.03% | -92.89% | Jun 2026 |
| Virtu Financial LLC | 11.1K | 0.02% | -77.37% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 10.7K | 0.02% | 0.00% | Jun 2026 |
| Mariner Wealth Advisors LLC | 10.0K | 0.02% | 0.00% | Jun 2026 |
| UBS Group AG | 9.77K | 0.02% | -76.93% | Jun 2026 |
| Group One Trading, LLC | 4.75K | 0.01% | -54.12% | Jun 2026 |
| Hanson Mcclain Inc | 2.85K | 0.01% | 0.00% | Jun 2026 |
MindWalk Holdings Corp. company profile
- Company name
- MindWalk Holdings Corp.
- Ticker
- HYFT.US
- ISIN
- CA6026871054
- Exchange
- USA Stocks
- Listed since
- Jan 3, 2017
- Sector
- Healthcare
- Industry
- IT Services
- Employees
- 74
- Fiscal year end
- April
- Address
- Industrious 823 Congress Ave, Austin, TX, United States, 78701
- Phone
- 800 620 4187
- Website
- mindwalkai.com
About MindWalk Holdings Corp.
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company is headquartered in Austin, Texas.
MindWalk Holdings Corp. management
8- Dr. Jennifer Lynne Bath Ph.D.CEO, President & Non-Independent Director
- Mr. Richard Scott AregladoChief Financial Officer · born 1964
- Ms. Kari GraberVice President of Commercial Services
- Dr. Shuji SatoVice President of Innovative Solutions
- Mr. Dirk Van Hyfte M.D., Ph.D.Chief Technology Officer
- Mr. Frederic ChabotHead of Corporate Development
- Ms. Ingrid Brands M.D., Ph.D.Chief Innovation & Strategy Officer
- Ms. Lori AndersonVice President of Brand Marketing and Creative